This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre L A, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424. doi: 10.3322/caac.21492BrayFFerlayJSoerjomataramISiegelR LTorreL AJemalAGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin20186839442410.3322/caac.2149230207593Open DOISearch in Google Scholar
Pang T, Wang S, Gao M, Kang H, Zhao Y, Yao Y, et al. HPV18 E7 induces the over-transcription of eIF4E gene in cervical cancer. Iran J Basic Med Sci 2015; 18: 684-90. PMID: 26351560PangTWangSGaoMKangHZhaoYYaoYet alHPV18 E7 induces the over-transcription of eIF4E gene in cervical cancerIran J Basic Med Sci20151868490PMID: 26351560Search in Google Scholar
Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550-60. doi: 10.1038/nrc2886MoodyCALaiminsLAHuman papillomavirus oncoproteins: pathways to transformationNat Rev Cancer2010105506010.1038/nrc288620592731Open DOISearch in Google Scholar
Santin A D, Zhan F, Bignotti E, Siegel E R, Cane S, Bellone S, et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005; 331: 269-91. doi: 10.1016/j.virol.2004.09.045SantinA DZhanFBignottiESiegelE RCaneSBelloneSet alGene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapyVirology20053312699110.1016/j.virol.2004.09.04515629771Open DOISearch in Google Scholar
Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world. Oncotarget 2014; 5: 10976-96. doi: 10.18632/ oncotarget.2770Di GesualdoFCapaccioliSLulliMA pathophysiological view of the long non-coding RNA worldOncotarget20145109769610.18632/oncotarget.2770429437325428918Open DOISearch in Google Scholar
Sun L, Luo H, Liao Q, Bu D, Zhao G, Liu C, et al. Systematic study of human long intergenic non-coding RNAs and their impact on cancer. Sci China Life Sci 2013; 56: 324-34. doi: 10.1007/s11427-013-4460-xSunLLuoHLiaoQBuDZhaoGLiuCet alSystematic study of human long intergenic non-coding RNAs and their impact on cancerSci China Life Sci2013563243410.1007/s11427-013-4460-x23504273Open DOISearch in Google Scholar
Ching T, Peplowska K, Huang S, Zhu X, Shen Y, Molnar J, et al. Pan-cancer analyses reveal long intergenic non-coding RNAs relevant to tumor diagnosis, subtyping and prognosis. EBioMedicine 2016; 7: 62-72. doi: 10.1016/j. ebiom.2016.03.023ChingTPeplowskaKHuangSZhuXShenYMolnarJet alPan-cancer analyses reveal long intergenic non-coding RNAs relevant to tumor diagnosis, subtyping and prognosisEBioMedicine20167627210.1016/j.ebiom.2016.03.023490936427322459Open DOISearch in Google Scholar
Yang M, Zhai X, Xia B, Wang Y, Lou G. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA. Tumour Biol 2015; 36: 7615-22. doi: 10.1007/s13277-015-3465-4YangMZhaiXXiaBWangYLouGLong noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNATumour Biol20153676152210.1007/s13277-015-3465-425921283Open DOISearch in Google Scholar
Han D, Wang J, Cheng G. LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis. Oncotarget 2018; 9: 2395-409. doi: 10.18632/oncotarget.23416HanDWangJChengGLncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axisOncotarget20189239540910.18632/oncotarget.23416578864829416780Open DOISearch in Google Scholar
Tian Z, Cao S, Li C, Xu M, Wei H, Yang H, et al. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1. J Cell Physiol 2019; 234: 4799-4811. doi: 10.1002/jcp.27279TianZCaoSLiCXuMWeiHYangHet alLncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1J Cell Physiol20192344799481110.1002/jcp.2727930317572Open DOISearch in Google Scholar
Chen Y, Du H, Bao L, Liu W. LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214. Cancer Biol Med 2018; 15: 238-250. doi: 10.20892/j.issn.2095-3941.2017.0174ChenYDuHBaoLLiuWLncRNA PVT1 promotes ovarian cancer progression by silencing miR-214Cancer Biol Med20181523825010.20892/j.issn.2095-3941.2017.0174612105530197791Open DOISearch in Google Scholar
Ding Y, Fang Q, Li Y, Wang Y. Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140. Mamm Genome 2019. doi: 10.1007/s00335-019-09808-1DingYFangQLiYWangYAmplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140Mamm Genome201910.1007/s00335-019-09808-131222482Open DOISearch in Google Scholar
Iden M, Fye S, Li K, Chowdhury T, Ramchandran R, Rader J S. The lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosis. PLoS One 2016; 11: e0156274. doi: 10.1371/journal. pone.0156274IdenMFyeSLiKChowdhuryTRamchandranRRaderJ SThe lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosisPLoS One201611e015627410.1371/journal.pone.0156274488378127232880Open DOISearch in Google Scholar
Dong G, Liang X, Wang D, Gao H, Wang L, Wang L, et al. High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation. Med Oncol 2014; 31: 57. doi: 10.1007/s12032-014-0057-xDongGLiangXWangDGaoHWangLWangLet alHigh expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferationMed Oncol2014315710.1007/s12032-014-0057-x24930006Open DOISearch in Google Scholar
Muhammad S, Tang Q, Wei L, Zhang Q, Wang G, Muhammad B U, et al. miRNA-30d serves a critical function in colorectal cancer initiation, progression and invasion via directly targeting the GNA13 gene. Exp Ther Med 2019; 17: 260-272. doi: 10.3892/etm.2018.6902MuhammadSTangQWeiLZhangQWangGMuhammadB Uet almiRNA-30d serves a critical function in colorectal cancer initiation, progression and invasion via directly targeting the GNA13 geneExp Ther Med20191726027210.3892/etm.2018.6902630739830651791Open DOISearch in Google Scholar
Ma H P, Kong W X, Li X Y, Li W, Zhang Y, Wu Y. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR. Oncol Rep 2019. doi: 10.3892/or.2019.6983MaH PKongW XLiX YLiWZhangYWuYmiRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFROncol Rep201910.3892/or.2019.6983636571130747217Open DOISearch in Google Scholar
Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136: 586-91. doi: 10.1016/j.cell.2009.02.005VenturaAJacksTMicroRNAs and cancer: short RNAs go a long wayCell20091365869110.1016/j.cell.2009.02.005391010819239879Open DOISearch in Google Scholar
Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y, et al. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Mol Cancer 2017; 16: 139. doi: 10.1186/s12943-017-0708-6FangZYinSSunRZhangSFuMWuYet almiR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1Mol Cancer20171613910.1186/s12943-017-0708-6556161828818100Open DOISearch in Google Scholar
Lan H, Chen W, He G, Yang S. miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. Biomed Pharmacother 2015; 75: 117-22. doi: 10.1016/j.biopha.2015.07.035LanHChenWHeGYangSmiR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRABiomed Pharmacother2015751172210.1016/j.biopha.2015.07.03526297547Open DOISearch in Google Scholar
Zhang Y, Xu J. MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression. Biochem Biophys Res Commun 2016; 473: 342-8. doi: 10.1016/j.bbrc.2016.03.116ZhangYXuJMiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expressionBiochem Biophys Res Commun2016473342810.1016/j.bbrc.2016.03.11627021683Open DOISearch in Google Scholar
Li J, Zou K, Yu L, Zhao W, Lu Y, Mao J, et al. MicroRNA-140 inhibits the epithelial-mesenchymal transition and metastasis in colorectal cancer. Mol Ther Nucleic Acids 2018; 10: 426-37. doi: 10.1016/j.omtn.2017.12.022LiJZouKYuLZhaoWLuYMaoJet alMicroRNA-140 inhibits the epithelial-mesenchymal transition and metastasis in colorectal cancerMol Ther Nucleic Acids2018104263710.1016/j.omtn.2017.12.022586239629499953Open DOISearch in Google Scholar
Dong P, Xiong Y, Hanley S J B, Yue J, Watari H. Musashi-2, a novel onco-protein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation. J Exp Clin Cancer Res 2017; 36: 150. doi: 10.1186/s13046-017-0617-yDongPXiongYHanley S J BYueJWatariHMusashi-2, a novel onco-protein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activationJ Exp Clin Cancer Res20173615010.1186/s13046-017-0617-y565903229073938Open DOISearch in Google Scholar
Dong J, Su M, Chang W, Zhang K, Wu S, Xu T. Long non-coding RNAs on the stage of cervical cancer. Oncol Rep 2017; 38: 1923-31. doi: 10.3892/ or.2017.5905DongJSuMChangWZhangKWuSXuTLong non-coding RNAs on the stage of cervical cancerOncol Rep20173819233110.3892/or.2017.590528849103Open DOISearch in Google Scholar
Zhang Y, Yang G, Luo Y. Long non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200a. Exp Ther Med 2019; 17: 1337-45. doi: 10.3892/etm.2018.7083ZhangYYangGLuoYLong non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200aExp Ther Med20191713374510.3892/etm.2018.7083632764530680011Open DOISearch in Google Scholar
Zou M F, Ling J, Wu Q Y, Zhang C X. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2. Eur Rev Med Pharmacol Sci 2018; 22: 7183-8. doi: 10.26355/eurrev_201811_16251ZouM FLingJWuQ YZhangC XLong non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2Eur Rev Med Pharmacol Sci2018227183810.26355/eurrev_201811_1625130468460Open DOISearch in Google Scholar
Wan L, Sun M, Liu G J, Wei C C, Zhang EB, Kong R, et al. Long noncoding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetically regulating LATS2 expression. Mol Cancer Ther 2016; 15: 1082-94. doi: 10.1158/1535-7163.MCT-15-0707WanLSunMLiuG JWeiC CZhangEBKongRet alLong noncoding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetically regulating LATS2 expressionMol Cancer Ther20161510829410.1158/1535-7163.MCT-15-070726908628Open DOISearch in Google Scholar
Ping G, Xiong W, Zhang L, Li Y, Zhang Y, Zhao Y. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer. Am J Transl Res 2018; 10: 138-49. PMID: 29423000PingGXiongWZhangLLiYZhangYZhaoYSilencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancerAm J Transl Res20181013849PMID: 29423000Search in Google Scholar
Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339: 159-66. doi: 10.1016/j. canlet.2013.06.013ShiXSunMLiuHYaoYSongYLong non-coding RNAs: a new frontier in the study of human diseasesCancer Lett20133391596610.1016/j.canlet.2013.06.01323791884Open DOISearch in Google Scholar
Kim J, Piao H L, Kim B J, Yao F, Han Z, Wang Y, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 2018; 50: 1705-15. doi: 10.1038/s41588-018-0252-3KimJPiaoH LKimB JYaoFHanZWangYet alLong noncoding RNA MALAT1 suppresses breast cancer metastasisNat Genet20185017051510.1038/s41588-018-0252-3626507630349115Open DOISearch in Google Scholar
Zhang R, Li J, Yan X, Jin K, Li W, Liu X, et al. Long noncoding RNA plasmacytoma variant translocation 1 (PVT1) promotes colon cancer progression via endogenous sponging miR-26b. Med Sci Monit 2018; 24: 8685-92. doi: 10.12659/MSM.910955ZhangRLiJYanXJinKLiWLiuXet alLong noncoding RNA plasmacytoma variant translocation 1 (PVT1) promotes colon cancer progression via endogenous sponging miR-26bMed Sci Monit20182486859210.12659/MSM.910955628663230504754Open DOISearch in Google Scholar
Huang V. Endogenous miRNAa: miRNA-mediated gene upregulation. Adv Exp Med Biol 2017; 983: 65-79. doi: 10.1007/978-981-10-4310-9_5HuangVEndogenous miRNAa: miRNA-mediated gene upregulationAdv Exp Med Biol2017983657910.1007/978-981-10-4310-9_528639192Open DOISearch in Google Scholar
Yamazaki K, Masugi Y, Effendi K, Tsujikawa H, Hiraoka N, Kitago M, et al. Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma. Lab Invest 2014; 94: 683-91. doi: 10.1038/labinvest.2014.53YamazakiKMasugiYEffendiKTsujikawaHHiraokaNKitagoMet alUpregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinomaLab Invest2014946839110.1038/labinvest.2014.5324709776Open DOISearch in Google Scholar
Fan Q, Qiu M T, Zhu Z, Zhou J H, Chen L, Zhou Y, et al. Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-beta/Smad3 signaling pathway. Oncol Rep 2015; 34: 1787-94. doi: 10.3892/or.2015.4143FanQQiuM TZhuZZhouJ HChenLZhouYet alTwist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-beta/Smad3 signaling pathwayOncol Rep20153417879410.3892/or.2015.414326239019Open DOISearch in Google Scholar
Chen X, Xiong D, Ye L, Wang K, Huang L, Mei S, et al. Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1. Cancer Cell Int 2019; 19: 45. doi: 10.1186/s12935-019-0744-yChenXXiongDYeLWangKHuangLMeiSet alUp-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1Cancer Cell Int2019194510.1186/s12935-019-0744-y639405730858762Open DOISearch in Google Scholar
Su Y, Xiong J, Hu J, Wei X, Zhang X, Rao L. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis. Oncotarget 2016; 7: 68397-411. doi: 10.18632/oncotarget.11722SuYXiongJHuJWeiXZhangXRaoLMicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasisOncotarget201676839741110.18632/oncotarget.11722535656427588393Open DOISearch in Google Scholar
Yang J P, Yang X J, Xiao L, Wang Y. Long noncoding RNA PVT1 as a novel serum biomarker for detection of cervical cancer. Eur Rev Med Pharmacol Sci 2016; 20: 3980-6.YangJ PYangX JXiaoLWangYLong noncoding RNA PVT1 as a novel serum biomarker for detection of cervical cancerEur Rev Med Pharmacol Sci20162039806Search in Google Scholar
